Skip to content

GL medEx

Active Private limited companyfounded 2011active for 14 yearsMaison du Bois 47, 4651 HerveKBO/BCE: BE 0841.318.810

Lifetime

14 annual accounts with figures on one time axis
peak of €157,468 in 2024
€63,796▼ 59.5%
peak of €99,738 in 2024
€30,814▼ 69.1%
peak of €69,379 in 2019
€14,260▼ 51.0%
€163,323▼ 23.6%
Board1 name since 2011
1 director
Documentsfilings and deeds
28-08-202628 days late
2025micro format
Gross margin from €157,468 to €63,796Result from €99,738 to €30,814Dividend €45,678Equity from €29,123 to €14,260Debts from €213,886 to €163,3231 establishment registered

Key points

from the 2025 annual accounts

Equity

€14,260 from €69,379 in 2019

Equity fell by 79% in 6 years.

Result

€30,814 ▼ 69.1%
€99,7002024€30,8002025

The result fell in 2025 from €99,738 to €30,814.

Turnover

≈ €140,000 estimated

The micro format states no turnover.

Debts

€163,323 92% of the balance sheet
Financial debts 54%Suppliers 1%Taxes and wages 38%Other 7%

Of this, €75,568 falls due within a year.

Filings

14 annual accounts since 2012
AprilJune31 JulyOctober201520202025

Eight of the last ten came late. The 2018 accounts came in latest, 91 days after the end of the period.

Position in the sector

8.0%

Lower solvency than 87% of companies in human health. The sector median is 63.0%, over 21,385 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 1,326 companies had the same profile as GL medEx has now. Each dot stands for 4 companies, two years later.

95.1%
were still trading
3.2%
stopped another way
1.4%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more

Another 0.2% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 1,326 companies, not a prediction for GL medEx. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager
  • 100 sharesdeed of 28-11-2011
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0841318810
First establishment Maison du Bois 47, Herve
Company renamed from Docteur Geoffrey LAMBERTY to GL medEx Legal-form conversion: to private limited company · General meeting of 24-11-2023 · Gazette deed
is in office as manager Gazette deed
All 23 events

Comparable companies

same main activity, similar in size and age
Company
GL medEx Herve €177,583 €63,796 8.0% -
Docteur Géraldine Blaise Seraing €197,838 €64,376 52.6% -
STELLIAN CAROLE Andenne €179,764 €62,444 75.5% -
Dr. I. Van Hul Beveren-Kruibeke-Zwijndrecht €172,103 €59,817 53.6% -
DR. E. CALLENS Sint-Pieters-Leeuw €175,664 €56,962 80.0% -
CABINET MEDICAL CLAES Aywaille €154,664 €73,240 97.4% -
CABINET MEDICAL DR CORMAN Sprimont €160,817 €76,927 31.7% -

These companies have the same main activity as GL medEx: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €155,000 and €198,000, founded between 2010 and 2012.

Official details

Source: KBO
Status
Active since 24-11-2011Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.382.428.5794651 Herve, since 01-12-2025
Financial year end
31 December
Peppol
Reachable since 09-12-2025
Company details

Annual accounts 2025

€177,583▼ 26.9%
Filing
Filed on 28-08-2026
Financials

Insights on GL medEx

GL medEx files the micro format. That format states no turnover. The gross margin fell from €67,020 in 2012 to €63,796 in 2025.

The balance sheet grew most from 2023 to 2024 through fixed assets, financed with long-term debt.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about GL medEx

What is the company number of GL medEx?
The company number of GL medEx is 0841.318.810. The VAT number is the same number with BE in front: BE 0841.318.810.
Where is GL medEx based?
The registered office is at Maison du Bois 47, 4651 Herve.Company details
What does GL medEx do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of GL medEx?
GL medEx is a private limited company (BV).
When was GL medEx founded?
GL medEx was founded on 24-11-2011.
Is GL medEx still active?
Yes, GL medEx is an active enterprise in the KBO register.
What is the turnover of GL medEx?
The turnover in financial year 2025 is about €140,000. This figure is estimated from the gross margin of €63,796 and 33 comparable companies (NACE 862). It probably lies between €110,000 and €180,000.Financials
Is GL medEx profitable?
In financial year 2025, GL medEx made a profit of €30,814.
Where can I find the annual accounts of GL medEx?
GL medEx filed 14 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of GL medEx due?
GL medEx must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.